Table 3.
Patient treatment characteristics. Values are median (interquartile range) or % (proportion) as indicated.
| Total | No BOM | BOM | p-value | |
|---|---|---|---|---|
| Procedure | ||||
| LHM | 50.4% (65/129) | 73.8% (48/65) | 26.2% (17/65) | 0.013 |
| POEM | 49.6% (64/129) | 90.6% (58/64) | 9.4% (6/64) | |
| Fundoplication | ||||
| Nissen | 4.6% (3/65) | 33.3% (1/3) | 66.7% (2/3) | 0.119 |
| Toupet | 33.8% (22/65) | 86.4% (19/22) | 13.6% (3/22) | |
| Dor | 43.1% (28/65) | 75.0% (21/28) | 25.0% (7/28) | |
| Unknown | 18.5% (12/65) | 58.3% (7/12) | 41.7% (5/12) | |
| Myotomy Length | ||||
| Esophageal (cm) | 6 (6 – 6) | 6 (6 – 6) | 6 (5.8 – 8.5) | 0.218 |
| Gastric (cm) | 3 (3 – 3) | 3 (3 – 3) | 3.0 (2.0 – 3.3) | 0.517 |
| Total (cm) | 9 (9 – 10) | 9 (9 – 10) | 9 (8 – 12.3) | 0.766 |
| Multiple/Prior Achalasia Therapies | ||||
| Total | 36.4% (47/129) | 80.9% (38/47) | 19.1% (9/47) | 0.767 |
| PD | 21.7% (28/129) | 82.1% (23/28) | 17.9% (5/28) | 0.738 |
| POEM | 1.6% (2/129) | 50.0% (1/2) | 50.0% (1/2) | |
| LHM | 6.2% (8/129) | 75.0% (6/8) | 25.0% (2/8) | |
| >2 Prior Treatments | 3.9% (5/129) | 80.0% (4/5) | 20.0% (1/5) | |
| Location | ||||
| NMH | 79.8% (103/129) | 86.4% (89/103) | 13.6% (14/103) | 0.012 |